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Abstract
Background: The purpose of the present investigation was to determine if the salivary counts of
40 common oral bacteria in subjects with an oral squamous cell carcinoma (OSCC) lesion would
differ from those found in cancer-free (OSCC-free) controls.
Methods:  Unstimulated saliva samples were collected from 229 OSCC-free and 45 OSCC
subjects and evaluated for their content of 40 common oral bacteria using checkerboard DNA-
DNA hybridization. DNA counts per ml saliva were determined for each species, averaged across
subjects in the 2 subject groups, and significance of differences between groups determined using
the Mann-Whitney test and adjusted for multiple comparisons. Diagnostic sensitivity and specificity
in detection of OSCC by levels of salivary organisms were computed and comparisons made
separately between a non-matched group of 45 OSCC subjects and 229 controls and a group of
45 OSCC subjects and 45 controls matched by age, gender and smoking history.
Results: Counts of 3 of the 40 species tested, Capnocytophaga gingivalis, Prevotella melaninogenica
and Streptococcus mitis, were elevated in the saliva of individuals with OSCC (p < 0.001). When
tested as diagnostic markers the 3 species were found to predict 80% of cancer cases (sensitivity)
while excluding 83% of controls (specificity) in the non-matched group. Diagnostic sensitivity and
specificity in the matched group were 80% and 82% respectively.
Conclusion: High salivary counts of C. gingivalis, P. melaninogenica and S. mitis may be diagnostic
indicators of OSCC.
Background
Each year nearly 30,000 Americans are diagnosed with
oral cancer. 90% of these lesions are oral squamous cell
carcinomas [1]. Despite advances in surgery, radiation
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and chemotherapy, the five-year survival rate is 54%, one
of the lowest of the major cancer sites, and this rate has
not improved significantly in recent decades [2-4]. World-
wide, the problem is much greater, with over 350,000 to
400,000 new cases being found each year [5]. The disease
kills one person every hour – more people than cancers of
the cervix, brain, ovary, testes, liver, kidney, malignant
melanoma or Hodgkin's lymphoma [5,6]. In the United
States, African American males suffer the highest inci-
dence and lowest survival rates of any group. From 1985
to 1996, the five-year survival rate for tongue carcinoma in
African-American men was 27%, compared with a 47%
five-year survival rate among white men [7]. In 2001, sim-
ilar five-year survival rates were found in a study of oral
and pharyngeal cancer among African-American and
White men [8]. Notably, incidence in young adults (<40
years) is increasing in the U.S. [9,10] and worldwide
[11,12].
Early detection followed by appropriate treatment, can
increase cure rates to 80 or 90%, and greatly improve the
quality of life by minimizing extensive, debilitating treat-
ments [5,13]. Despite the accessibility of the oral cavity to
direct examination, these malignancies are often not
detected until a late stage [5,14,15]. Oral cancer is unusual
in that it carries a high risk of second primary tumors.
Patients who survive a first cancer of the oral cavity have
up to a 20-fold increased risk of developing a second pri-
mary oral cancer and that risk lasts 5–10 years and some-
times longer [16].
Major risk factors for oral cancers in the United States are
use of tobacco and alcohol, which account for 75 to 80%
of all oral cancers [5,17]. Although tobacco is a well-rec-
ognized risk factor for OSCC, the public is generally una-
ware that alcohol synergizes with tobacco. Those who
both smoke and drink have 15 times the risk of develop-
ing oral cancer [5]. Notably, some oral cancer patients
have no known risk factors, and the disease in this popu-
lation may pursue a particularly aggressive course [18].
The American Cancer Society recommends that doctors
and dentists examine the mouth and throat during rou-
tine examinations [2] as early cancer lesions are often
asymptomatic and may mimic benign lesions [19,20].
General population screening, however, has not been
shown to reduce the incidence of and mortality from oral
cancer. The reasons include the low prevalence and inci-
dence of OSCC, the potential for false-positive diagnoses
and poor compliance with screening and referral [6,21].
Thus the National Institute of Dental and Craniofacial
Research and The Oral Cancer Foundation have recom-
mended that research efforts focus on developing novel
detection techniques [5,16].
Studies have reported that certain common oral bacteria
are elevated on or in oral and esophageal cancer lesions
and their associated lymph nodes [22-28]. Although
increased colonization of facultative oral streptococci
have been reported most often [24-27], anaerobic Prevo-
tella, Veillonella, Porphyromonas and Capnocytophaga species
were also elevated [25,26,28]. Currently, studies are exam-
ining whether bacteria may be incidentally or causally
associated with oral cancer. Additional research is deter-
mining whether various salivary markers may be used as
early diagnostic indicators for oral cancer.
The reason for these shifts in bacterial colonization of can-
cer lesions is unclear. Mechanistic studies of bacterial
attachment provide some insights, however. Research has
repeatedly shown that oral bacteria demonstrate specific
tropisms toward different biological surfaces in the oral
cavity such as the teeth, mucosa, and other bacteria [29-
35]. The non-shedding surfaces of the teeth offer a far dif-
ferent habitat than the continually shedding surfaces of
the oral mucosa. Due to the repeated shedding of epithe-
lial cells, there is less time for a complex biofilm to
develop on soft tissue surfaces; thus, a premium is placed
on potent mechanisms of adhesion. The differences in
bacterial tropisms for specific oral sites suggest that differ-
ent intra-oral surfaces and bacterial species have different
receptors and adhesion molecules that dictate the coloni-
zation of different oral surfaces.
It is now recognized that bacteria bind to and colonize
mucosal surfaces in a highly selective manner via a "lock-
and key" mechanism. Adhesins on bacteria bind specifi-
cally to complementary receptors on the mucosal surfaces
of the host. These adhesins differ from species to species
leading to specificity in attachment to different surfaces.
Studies have shown that even within genera, colonization
patterns of individual species may differ markedly [29-
32]. Streptococcus salivarius, for example, preferentially col-
onized the oral soft tissues and saliva compared to the
teeth, while the reverse was true of Streptococcus sanguis.
Cancer has been referred to as a molecular disease of cell
membrane glycoconjugates, [36-38]. Certain glycoconju-
gates serve as receptors for specific bacteria and recent
reports support the notion that shifts in the colonization
of different cancer cells are associated with observed
changes in cell surface receptors [36,40,41]. An in vitro
study of S. sanguis, a common oral inhabitant, demon-
strated that its binding capacity to normal exfoliated
human buccal epithelial cells (HBEC) depended upon the
availability of surface sialic acid residues [36]. Desialyla-
tion of HBEC invariably abolished adhesion of S. sanguis
to these epithelial cells. In similar experiments carried out
with a buccal carcinoma cell line, S. sanguis did not relia-
bly attach. It was determined that the tumor cells did notJournal of Translational Medicine 2005, 3:27 http://www.translational-medicine.com/content/3/1/27
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express the sialylated membrane glycoprotein of normal
cells suggesting that changes in the surface receptors had
occurred in the buccal carcinoma cell line.
In a previous study of 225 OSCC-free subjects we found a
high degree of specificity in the "preferred" intra-oral
localization of species, even within a single genus such as
Streptococcus [42]. This specificity in localization of indi-
vidual species agreed with that described in previous stud-
ies. Our investigation extended earlier findings by
describing the distribution of multiple species within the
same genus on a wider range of intra-oral surfaces. For
example, S. oralis, S. constellatus, S. mitis, S. intermedius and
S. anginosus colonized the soft tissues in higher propor-
tions than the teeth; however, their "preferred" soft tissue
habitats differed. S. sanguis colonized different soft tissue
locations in similar proportions, but was found in higher
mean proportions on the teeth, particularly in the suprag-
ingival plaque.
The availability of a large amount of data from the OSCC-
free subjects permitted this group to be subset according
to periodontal and smoking status and the colonization
patterns on the soft tissues compared among groups [43].
The clinical parameters among the populations were in
accord with those found in previous studies and results
were similar to previous investigations [44-47]. Few dif-
ferences were found in the salivary or soft tissue microbi-
ota among the subset populations. It was concluded that
the presence or absence of periodontal infections or a
smoking habit had minimal effects on salivary and soft
tissue colonization. These findings were in accord with
studies by Danser et al. 1996 and Lie et al. 1998 [48,49]
but contrasted with earlier reports by Colman et al. 1976
and van Winkelhoff et al. 1986 [50,51]. Importantly, we
found that when the microbiota of teeth, soft tissues and
saliva were compared, the microbial profile of saliva was
similar to that of the soft tissues, but saliva and soft tissue
colonization differed markedly from that of dental
plaque. These findings were similar to those of other
investigations [46,51,52].
As previously mentioned, studies have reported that the
microbiota of OSCC lesions differs from that found on
the soft tissues of OSCC-free individuals. Little was
known, however, about the salivary microbiota of oral
cancer subjects. Thus, the purpose of the present investiga-
tion was to determine whether the salivary microbiota in
subjects with an oral squamous cell carcinoma (OSCC)
lesion would differ from that found in OSCC-free
controls.
Materials and methods
OSCC-free Population
A total of 229 OSCC-free subjects were recruited from the
patient pool at The Forsyth Institute. All subjects were 18
years or older, and immunocompetent. Exclusion criteria
included: antibiotic therapy within the previous 3
months, pregnancy or lactation, systemic conditions asso-
ciated with immune dysfunction (e.g., diabetes), previous
chemotherapy or radiation and the presence of any oral
mucosal lesions.
Oral Cancer Population
A total of 45 subjects diagnosed with OSCC via biopsy
were recruited from the Partners' Hospitals (The Dana Far-
ber Cancer Institute, Brigham and Women's Hospital and
Massachusetts General Hospital). Inclusion criteria
required that subjects be 18 years or older and immuno-
competent, with a primary untreated OSCC. Exclusion cri-
teria included systemic conditions associated with
immune dysfunction (e.g., diabetes), previous chemo-
therapy or radiation, an inability to properly consent,
and/or lesions that could not be sampled due to discom-
fort, anatomic location or that did not affect the surface
oral epithelium. In the unmatched comparisons OSCC
subjects were older and included a higher percentage of
male subjects and smokers than OSCC-free subjects
(Table 1). Thus a subset of 45 controls was matched by
computer for age, gender and smoking with the 45 OSCC
subjects (Table 2).
Table 1: Age, gender and smoking status of 229 OSCC-free and 
45 OSCC subjects.
OSCC-free OSCC
N 229 45
Mean Age (±SEM) 42.06 (±1.04) 57.6 (±2.34)
Minimum Age 18 18
Maximum Age 81 92
% Males (N) 47% (107) 71% (32)
% Smokers (N) 20% (46) 40% (18)
Table 2: Age, gender and smoking status of 45 OSCC-free and 45 
OSCC subjects matched by age, gender and smoking history
OSCC-free OSCC
N4 5 4 5
Age Mean (±SEM) 53.67 (±2.06) 54.46 (±2.27)
Age Min 19 18
Age Max 81 85
Males 32 32
Smokers 18 18Journal of Translational Medicine 2005, 3:27 http://www.translational-medicine.com/content/3/1/27
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Collection of samples and preparation of test membranes
Whole unstimulated saliva samples were collected by
expectoration from 229 OSCC-free and 45 OSCC sub-
jects. Samples were evaluated for their content of 40 com-
mon oral bacteria using checkerboard DNA-DNA
hybridization as described by Socransky et al. [53] and
whole genomic probes were prepared by the method
described by Smith et al. (1989) [54]. The concentration
of the purified DNA was determined by spectrophotomet-
ric measurement of the absorbance at 260 nm and purity
of the preparations was assessed by the ratio of the
absorbances at 260 and 280 nm. Whole genomic DNA
probes were prepared from each of the 40 test strains by
labeling 1–3 µg DNA with digoxigenin (Boehringer Man-
nheim, Indianapolis IN.) using a random primer tech-
nique [55]. The membranes were prehybridized to block
nonspecific binding. The 40 species examined are com-
monly found in the oral cavity and are listed in Table 3
with their corresponding American Type Culture Collec-
tion (ATCC) numbers. Two lanes in each run had stand-
ards at 105 and 106 cells of each species and signals were
converted to absolute counts by comparison with stand-
ards on the membrane. Signals were detected using a
Storm Fluorimager (Molecular Dynamics, Sunnyvale CA).
The sensitivity of this assay also detected 104 cells of a
given species by adjusting the concentration of each DNA
probe. Failure to detect a signal was recorded as zero,
although counts in the 1 to 1000 range could have been
present. Data available for all subjects were compared
using the Mann-Whitney test and Bonferroni adjustment
performed for multiple comparisons.
Results
Unmatched subjects
The levels of salivary bacteria in subjects with and without
OSCC are illustrated in Fig 1. Comparisons between the
229 OSCC-free and 45 OSCC subjects indicated that 6
common oral bacteria (P. melaninogenica,  C. gingivalis,
Capnocytophaga ochracea,  Eubacterium saburreum,  Leptot-
richia buccalis and S. mitis) differed (p < 0.001). Elevated
salivary counts of ≥0.4 × 105/ml of 3 bacteria, C. gingivalis,
P. melaninogenica and S mitis, were found to have diagnos-
tic sensitivity and specificity ≥80%. The remaining species,
including the three bacteria that were recovered in lower
levels in salivary samples of OSCC patients, E. saburreum,
L. buccalis, and C. ochracea, did not contribute significantly
to the diagnostic test as their diagnostic sensitivity and
specificity values were ≤60%.
Diagnostic sensitivity and specificity for different counts
of C. gingivalis, P. melaninogenica and S. mitis/ml saliva for
the unmatched populations are illustrated in Figure 2. C.
gingivalis was the species most closely associated with oral
cancer lesions but diagnostic sensitivity and specificity
was highest when levels of the 3 bacteria were each ≥0.4 ×
105. Median DNA probe counts of C. gingivalis P. melani-
nogenica  and S. mitis in OSCC-free subjects were 0.25,
0.63, and 0.31 × 105 per ml of saliva. In contrast, the
median DNA probe counts of these 3 species in the 45
OSCC subjects were 3.24, 5.62 and 1.62 × 105 per ml of
saliva, respectively.
Matched Subjects
45 OSCC-free controls were matched by computer for age,
gender and smoking history with the 45 OSCC subjects.
Diagnostic sensitivity and specificity for detection of oral
cancer using levels of salivary bacteria were computed as
Table 3: The 40 test strains employed for the development of 
DNA probes.
Microorganism ATCC number
Actinobacillus actinomycetemcomitans 43718 and 29523
Actinomyces gerencseriae 23860
Actinomyces israelii 12102
Actinomyces naeslundii genospecies 1 12104
Actinomyces naeslundii genospecies 2 43146
Actinomyces odontolyticus 17929
Campylobacter gracilis 33236
Campylobacter rectus 33238
Campylobacter showae 51146
Capnocytophaga gingivalis 33624
Capnocytophaga ochracea 33596
Capnocytophaga sputigena 33612
Eikenella corrodens 23834
Eubacterium nodatum 33099
Eubacterium saburreum 33271
Fusobacterium nucleatum ss nucleatum 25586
Fusobacterium nucleatum ss polymorphum 10953
Fusobacterium nucleatum ss vincentii 49256
Fusobacterium periodonticum 33693
Gemella morbillorum 27824
Leptotrichia buccalis 14201
Neisseria mucosa 19696
Peptostreptococcus micros 33270
Porphyromonas gingivalis 33277
Prevotella intermedia 25611
Prevotella melaninogenica 25845
Prevotella nigrescens 33563
Propionibacterium acnes 11827 and 11828
Selenomonas noxia 43541
Streptococcus anginosus 33397
Streptococcus constellatus 27823
Streptococcus gordonii 10558
Streptococcus intermedius 27335
Streptococcus mitis 49456
Streptococcus oralis 35037
Streptococcus sanguis 10556
Tannerella forsythensis 43037
Treponema denticola B1
Treponema socranskii S1
Veillonella parvula 10790Journal of Translational Medicine 2005, 3:27 http://www.translational-medicine.com/content/3/1/27
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described above. The results for the matched population
were similar to those for the unmatched comparisons
namely that the increased counts of C. gingivalis, P. mela-
ninogenica and S. mitis were 80% diagnostically sensitive
and 82% diagnostically specific for the presence of OSCC
(Figure 3). As before, the remaining 37 species did not
improve sensitivity or specificity.
Discussion
Results from this investigation demonstrated that oral
cancer subjects had elevated counts (p < 0.001) of C. gin-
givalis, P. melaninogenica and S. mitis in saliva compared to
OSCC-free subjects. These results are borderline in signif-
icance after adjusting for multiple comparisons. However,
when each species was ≥0.4 × 105 they indicated the pres-
ence of an OSCC lesion with 80% diagnostic sensitivity
and ≥82% specificity in both matched and unmatched
populations.
The reason for this finding is unclear. One explanation
may relate to the altered cell surface receptors observed in
cancer cells [36,39,41]. It seems reasonable that altera-
tions in tumor cell receptors could change the adhesion of
certain species of bacteria. This was shown, as previously
discussed, in an in vitro study of HBEC and buccal cell car-
cinoma cell lines using the common oral bacterium S. san-
guis  by Neeser [36]. One might expect that as Neeser
found decreased colonization of S. sanguis, a similar study
using S. mitis would result in a reduced colonization of
oral cancer cells. Interestingly, our previous investigation
Salivary counts for the 40 test species in both populations Figure 1
Salivary counts for the 40 test species in both populations. Mean counts (±SD) of 40 test species in saliva samples of 
229 OSCC-free & 45 OSCC subjects (*** = p < 0.001).
15 12 9 6 3 0 3 6 9 12 15
G. morbillorum
*** E. saburreum
*** L. buccalis
F. nucleatum ss vincentii
E. nodatum
C. gracilis
T. socranskii
P. acnes
A. israelii
S. intermedius
A. naeslundii 1
S. constellatus
S. anginosus
C. sputigena
C. showae
S. noxia
T.forsythensis
      T. denticola
A. actinomycetemcomitans
P. micros
A. gerencseriae
S. gordonii
*** C. ochracea
P. intermedia
C. rectus
S. oralis
       P. gingivalis
S. sanguis
F. nucleatum ss polymorphum
A. naeslundii 2
P. nigrescens
F. periodonticum
F. nucleatum ss nucleatum
*** S. mitis
E. corrodens
V. parvula
N. mucosa
A. odontolyticus
*** C. gingivalis
*** P. melaninogenica
Counts x 10
5/ml
OSCC-
free
OSCC
positive
*** = p < 0.001Journal of Translational Medicine 2005, 3:27 http://www.translational-medicine.com/content/3/1/27
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of 225 OSCC-free subjects provided evidence to the con-
trary. Colonization of different oral sites differed among
the 40 test species, even among those of the same genera,
such as streptococci. For example, S. sanguis and S. mitis
both colonized the oral soft and hard tissues; however,
marked differences in their proportions at these sites were
noted. Highly species-specific oral colonization by strep-
tococci has been reported by other investigators [29-
32,57,58].
Saliva was found to be similar in microbial profile to the
soft tissues. This was a significant finding from the study
of the OSCC-free population. In contrast, the microbiota
of the teeth and saliva differed markedly. These results
agreed with previous studies [30,57,58]. Thus, if altera-
tions in bacterial adhesion to OSCC cells observed in vitro
exist  in vivo, colonization of OSCC lesions would be
affected. Shifts in the soft tissue microbiota of the oral cav-
ity appear likely to affect salivary levels as well.
A screening test for oral cancer based on salivary counts of
bacterial species is appealing. Saliva is now meeting the
demand for inexpensive, noninvasive, and easy-to use
diagnostic aids for oral and systemic diseases, and for
assessing risk behaviors such as tobacco and alcohol use.
Detection of HIV by the presence of virus-specific anti-
bodies in saliva, for example, has led to the development
of commercially available test kits [16]. If increased num-
bers of certain salivary species are shown to be a signature
of oral cancer, an early diagnostic test for OSCC may be
developed, reducing the morbidity and mortality of this
devastating cancer.
Studies to examine the validity of these findings are
planned. If the results of this study are validated it will be
important to address whether oral bacteria can be used as
indicators of oral cancer and whether certain oral species
contribute to carcinogenesis.
Conclusion
Results of the present study suggest that high salivary
counts of C. gingivalis, P. melaninogenica and S. mitis may
be diagnostic indicators of OSCC. These findings taken
with those of an earlier study indicate that the presence of
an OSCC has a more powerful effect on the salivary
microbiota than either smoking or periodontal infections.
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